Education
About Us
Working with TipRanks
Follow Us
Basel Medical Group Ltd (BMGL)
:BMGL
Total Valuation
Basel Medical Group Ltd has a market cap or net worth of $17.34M. The enterprise value is ―.
Market Cap$17.34M
Enterprise Value―
Share Statistics
Basel Medical Group Ltd has 18,785,750 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,785,750
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Basel Medical Group Ltd’s return on equity (ROE) is -2.49 and return on invested capital (ROIC) is -25.47%.
Return on Equity (ROE)-2.49
Return on Assets (ROA)-0.72
Return on Invested Capital (ROIC)-25.47%
Return on Capital Employed (ROCE)-0.35
Revenue Per Employee353.75K
Profits Per Employee-390.80K
Employee Count32
Asset Turnover0.67
Inventory Turnover6.71
Valuation Ratios
The current PE Ratio of Basel Medical Group Ltd is ―. Basel Medical Group Ltd’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio0.00
Income Statement
In the last 12 months, Basel Medical Group Ltd had revenue of 11.32M and earned -12.09M in profits. Earnings per share was 0.00.
Revenue11.32M
Gross Profit8.79M
Operating Income-2.18M
Pretax Income-12.51M
Net Income-12.09M
EBITDA-11.12M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Basel Medical Group Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.07
52-Week Price Change-80.68%
50-Day Moving Average1.40
200-Day Moving Average―
Relative Strength Index (RSI)18.22
Average Volume (3m)105.98K
Important Dates
Basel Medical Group Ltd upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Basel Medical Group Ltd as a current ratio of 1.23, with Debt / Equity ratio of ―
Current Ratio1.23
Quick Ratio1.19
Debt to Market Cap0.00
Net Debt to EBITDA-0.04
Interest Coverage Ratio-10.70
Taxes
In the past 12 months, Basel Medical Group Ltd has paid -417.39K in taxes.
Income Tax-417.39K
Effective Tax Rate0.03
Enterprise Valuation
Basel Medical Group Ltd EV to EBITDA ratio is -0.04, with an EV/FCF ratio of -0.10.
EV to Sales0.04
EV to EBITDA-0.04
EV to Free Cash Flow-0.10
EV to Operating Cash Flow-0.10
Balance Sheet
Basel Medical Group Ltd has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share$0.00
Margins
Gross margin is ―, with operating margin of -19.28%, and net profit margin of -106.78%.
Gross Margin―
Operating Margin-19.28%
Pretax Margin-110.47%
Net Profit Margin-106.78%
EBITDA Margin-98.24%
EBIT Margin-108.67%
Analyst Forecast
The average price target for Basel Medical Group Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―